| Total group (N = 50) | Amyloid-beta positive (n = 23) | Amyloid-beta negative (n = 27) | p-value |
---|---|---|---|---|
Age, years, mean ± SD | 68.4 ± 6.2 | 69.6 ± 6.3 | 67.3 ± 6.0 | 0.193a |
Female, n (%) | 29 (58.0) | 13 (56.5) | 16 (59.3) | 0.845d |
Education, years, mean ± SD | 15.3 ± 3.8 | 15.2 ± 4.6 | 15.3 ± 3.0 | 0.944b |
Cohort | Â | Â | Â | 0.233d |
 AMYPAD PNHS, n (%) | 34 (68.0) | 13 (56.5) | 21 (77.8) |  |
 SCIENCe, n (%) | 12 (24.0) | 8 (34.8) | 4 (14.8) |  |
 ADC, n (%) | 4 (8.0) | 2 (8.7) | 2 (7.4) |  |
Amyloid-beta biomarkers | Â | Â | Â | 0.508d |
 Cerebrospinal Fluid, n (%) | 5 (10.0) | 3 (13.0) | 2 (7.4) |  |
 Positron Emission Tomography, n (%) | 45 (90.0) | 20 (87.0) | 25 (92.6) |  |
Mini-Mental State Examination, mean ± SD | 29.2 ± 1.0 | 28.8 ± 1.1 | 29.5 ± 0.7 | 0.012c |